Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging.

Literature DB >> 1645666

Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging.

J Lekakis¹, N Vassilopoulos, H Psichoyiou, P Athanassiadis, S Gerali, P Kostamis, S Moulopoulos.

Abstract

A patient with primary hepatoma, treated with doxorubicin and presenting with atypical electrocardiographic findings, was investigated with myosin-specific monoclonal antibody radiolabelled with indium-111. Despite a normal ejection fraction, myosin-specific scintigraphy was positive, indicating doxorubicin cardiotoxicity.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1991 PMID： 1645666 DOI： 10.1007/bf02262734

Source DB: PubMed Journal: Eur J Nucl Med ISSN： 0340-6997

10 in total

1. High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy.

Authors: D Obrador; M Ballester; I Carrió; L Bernà; G Pons-Lladó
Journal: J Am Coll Cardiol Date: 1989-05 Impact factor: 24.094

2. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies.

Authors: B A Khaw; J T Fallon; G A Beller; E Haber
Journal: Circulation Date: 1979-12 Impact factor: 29.690

3. Indium-111-antimyosin images compared with triphenyl tetrazolium chloride staining in a patient six days after myocardial infarction.

Authors: D Jain; J C Crawley; A Lahiri; E B Raftery
Journal: J Nucl Med Date: 1990-02 Impact factor: 10.057

4. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres.

Authors: B A Khaw; J Scott; J T Fallon; S L Cahill; E Haber; C Homcy
Journal: Science Date: 1982-09-10 Impact factor: 47.728

5. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.

Authors: J Alexander; N Dainiak; H J Berger; L Goldman; D Johnstone; L Reduto; T Duffy; P Schwartz; A Gottschalk; B L Zaret
Journal: N Engl J Med Date: 1979-02-08 Impact factor: 91.245

6. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy.

Authors: J W Mason; M R Bristow; M E Billingham; J R Daniels
Journal: Cancer Treat Rep Date: 1978-06

7. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab.

Authors: B A Khaw; T Yasuda; H K Gold; R C Leinbach; J A Johns; M Kanke; M Barlai-Kovach; H W Strauss; E Haber
Journal: J Nucl Med Date: 1987-11 Impact factor: 10.057

8. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis.

Authors: T Yasuda; I F Palacios; G W Dec; J T Fallon; H K Gold; R C Leinbach; H W Strauss; B A Khaw; E Haber
Journal: Circulation Date: 1987-08 Impact factor: 29.690

9. Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics.

Authors: B Marchandise; E Schroeder; A Bosly; C Doyen; P Weynants; R Kremer; H Pouleur
Journal: Am Heart J Date: 1989-07 Impact factor: 4.749

10. Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial.

Authors: L L Johnson; D W Seldin; L C Becker; N D LaFrance; H A Liberman; C James; J A Mattis; R T Dean; J Brown; A Reiter
Journal: J Am Coll Cardiol Date: 1989-01 Impact factor: 24.094